Details of Drug

Drug General Information (ID: D1120)
Drug Name	Neomycin
Drug Type	Small molecule
Drug Synonymous	Neomycin; neomycin; NEOMYCIN B; Soframycin; Actiline; Mycifradin; Fradiomycin; Soframycine; Framycetinum; Framycetine; Framicetina; Neomas; Fradiomycinum; Antibiotique; Nivemycin; Actilin; Neolate; Enterfram; Myacyne; Framygen; Caswell No 595; Vonamycin powder V; Neomycin B sulfate; Neomin; Neomcin; Fradiomycin B; Neo-Rx; Neomicina [DCIT]; Framycetinum [INN-Latin]; PIMAVECORT; Neobrettin; Neo-Fradin; 119-04-0; Neomycine [INN-French]; Neomycinum [INN-Latin]; Framycetine [INN-French]; Framicetina [INN-Spanish]; USAF CB-19; Endomixin; Fraquinol; Myacine; Myciguent; NMY; Neobiotic; Neomicina; Neomycinum; Tuttomycin; VONAMYCIN; NEOMYCIN AND POLYMYXIN B SULFATES; NEOMYCIN SULFATE; Neomycin solution; Soframycin Ophthalmic; Antibiotic 10676; Antibiotic produced by Streptomyces decaris Neomycin B; Framycetin (INN); Soframycin (TN); Framycetin [INN:BAN:DCF]; Sofra-Tulle (TN); BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG; BDG-(1-4)NEB-(5-1)RIB-(3-1)NED; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol; D-Streptamine, O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1->3)-O-beta-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1->4)]-2-deoxy Click to Show/Hide
Disease Class	DB94: Alcoholic liver disease; DB91: Acute/subacute hepatic failure; 1A00-1C4Z: Bacterial infection
Therapeutic Class	Antibiotics
Structure
Structure	3D Structure		2D Structure
Formula	C23H46N6O13
InChI	1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1
InChIKey	PGBHMTALBVVCIT-VCIWKGPPSA-N
Canonical SMILES	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N
External Link
	Pubchem ID	8378
	CAS Number	119-04-0
	CHEBI ID	7508
	TTD ID	D05JNI
	INTEDE ID	DR2158

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM003 Affected organization distribution AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM002 Altered intestinal flora BM009 Altered absorption (Unspecific) BM014 Interference of cell/tissue uptake BM027 Decreased renal excretion due to nephrotoxicity BM045 Additive neuromuscular blocking effects BM063 Increased risk of hypocalcemia BM066 Increased risk of hypomagnesemia BM072 Increased risk of nephrotoxicity BM073 Increased risk of ototoxicity BM100 Antagonize the effect of vaccine/toxoid BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Neomycin
Affected gastrointestinal absorption
	Altered intestinal flora					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1094		Mycophenolate mofetil	C23H31NO7	5281078	Moderate		Inter Info	[161], [162]
D1095		Mycophenolic acid	C17H20O6	446541	Moderate		Inter Info	[161], [162]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[53], [55], [176], [177]
	Altered absorption (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[158], [159], [160]
D1268		Phenoxymethylpenicillin	C16H18N2O5S	6869	Moderate		Inter Info	[175], [53], [55]
D0491		Digoxin	C41H64O14	2724385	Minor		Inter Info	[185], [186], [187]
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1817		Indium In-111 oxyquinoline	C27H18InN3O3	16685037	Moderate		Inter Info	[165]
Affected excretion pathways
	Decreased renal excretion due to nephrotoxicity					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0576		Entecavir	C12H15N5O3	135398508	Moderate		Inter Info	[141]
D0668		Flucytosine	C4H4FN3O	3366	Moderate		Inter Info	[164]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[53], [55], [169], [170], [171]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[172]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[173]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[174]
Pharmacodynamic additive effects
	Additive neuromuscular blocking effects					Drug Num: 17
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0196		Botulinum toxin type A	NA	NA	Major		Inter Info	[4], [5], [6]
D0197		Botulinum Toxin Type B	NA	NA	Major		Inter Info	[4], [5], [6]
D0343		Cisatracurium	C53H72N2O12+2	62887	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D0975		Magnesium sulfate	MgO4S	24083	Major		Inter Info	[72], [73], [53], [74], [75]
D0122		Atracurium	C53H72N2O12+2	47319	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D0522		Doxacurium	C56H78N2O16+2	60169	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1047		Metocurine	C40H48N2O6+2	21233	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1080		Mivacurium	C58H80N2O14+2	5281042	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1219		Pancuronium	C35H60N2O4+2	441289	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1295		Pipecuronium	C35H62N4O4+2	50192	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1384		Rapacuronium	C37H61N2O4+	5311399	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1659		Tubocurarine	C37H41N2O6+	6000	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1684		Vecuronium	C34H57N2O4+	39765	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1420		Rocuronium	C32H53N2O4+	441290	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1510		Succinylcholine	C14H30N2O4+2	5314	Major		Inter Info	[26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1122		Neostigmine	C12H19N2O2+	4456	Moderate		Inter Info	[26], [53], [55], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
D1365		Pyridostigmine	C9H13N2O2+	4991	Moderate		Inter Info	[26], [53], [55], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [1], [38], [39], [40], [41]
	Increased risk of hypocalcemia					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0694		Foscarnet	CH3O5P	3415	Major		Inter Info	[49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [1], [64], [65], [66], [67], [68]
D0034		Alendronic acid	C4H13NO7P2	2088	Moderate		Inter Info	[86], [87], [88]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[146], [147], [148], [87], [149], [150], [151], [152], [153], [88], [154]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[86], [87], [88]
D1584		Tiludronic acid	C7H9ClO6P2S	60937	Moderate		Inter Info	[86], [87], [88]
D1217		Pamidronic acid	C3H11NO7P2	4674	Moderate		Inter Info	[86], [87], [88]
D1412		Risedronic acid	C7H11NO7P2	5245	Moderate		Inter Info	[86], [87], [88]
D1727		Zoledronic acid	C5H10N2O7P2	68740	Moderate		Inter Info	[146], [147], [148], [87], [149], [150], [151], [152], [153], [88], [154]
	Increased risk of hypomagnesemia					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[131], [132], [133]
D0603		Esomeprazole	C17H19N3O3S	9568614	Moderate		Inter Info	[142]
D0892		Lansoprazole	C16H14F3N3O2S	3883	Moderate		Inter Info	[142]
D0458		Dexlansoprazole	C16H14F3N3O2S	9578005	Moderate		Inter Info	[142]
D1373		Rabeprazole	C18H21N3O3S	5029	Moderate		Inter Info	[142]
D1179		Omeprazole	C17H19N3O3S	4594	Moderate		Inter Info	[142]
D1222		Pantoprazole	C16H15F2N3O4S	4679	Moderate		Inter Info	[142]
	Increased risk of nephrotoxicity					Drug Num: 73
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0142		Bacitracin	C66H103N17O16S	10909430	Major		Inter Info	[1], [2], [3]
D0217		Bumetanide	C17H20N2O5S	2471	Major		Inter Info	[7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [1], [17], [18], [19], [20], [21], [22], [23], [24]
D0252		Capreomycin	C50H88N28O15	3000502	Major		Inter Info	[1], [2], [3]
D0335		Cidofovir	C8H14N3O6P	60613	Major		Inter Info	[25]
D0472		Diatrizoate	C11H9I3N2O4	2140	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0704		Furosemide	C12H11ClN2O5S	3440	Major		Inter Info	[7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [1], [17], [18], [19], [20], [21], [22], [23], [24]
D0765		Human immunoglobulin G (intravenous)	NA	NA	Major		Inter Info	[69], [70], [71]
D0978		Mannitol	C6H14O6	6251	Major		Inter Info	[7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [1], [17], [18], [19], [20], [21], [22], [23], [24]
D0383		Colistimethate	C58H105N16O28S5-5	70789202	Major		Inter Info	[1], [2], [3]
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[76], [77]
D0629		Everolimus	C53H83NO14	6442177	Major		Inter Info	[78], [79], [80]
D0709		Gallium nitrate	GaN3O9	61635	Major		Inter Info	[81]
D0761		Human botulinum neurotoxin A/B immune globulin	NA	NA	Major		Inter Info	[69], [70], [71]
D0768		Human Rho(D) immune globulin	NA	NA	Major		Inter Info	[69], [70], [71]
D0805		Inotersen	C230H318N69O121P19S19	121492004	Major		Inter Info	[55], [82]
D0831		Iodipamide	C20H14I6N2O6	3739	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0832		Iodixanol	C35H44I6N6O15	3724	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0836		Iopromide	C18H24I3N3O8	3736	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0838		Ioversol	C18H24I3N3O9	3741	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D0839		Ioxilan	C18H24I3N3O8	3743	Major		Inter Info	[42], [43], [44], [45], [46], [47], [48]
D1549		Temsirolimus	C56H87NO16	6918289	Major		Inter Info	[78], [79], [80]
D1310		Polymyxin B	C56H98N16O13	49800004	Major		Inter Info	[1], [2], [3]
D1476		Sirolimus	C51H79NO13	5284616	Major		Inter Info	[78], [79], [80]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[78], [79], [80]
D1611		Torasemide	C16H20N4O3S	41781	Major		Inter Info	[8], [19], [24]
D0056		Amikacin	C22H43N5O13	37768	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D0057		Amikacin (liposome)	C22H43N5O13	37768	Moderate		Inter Info	[55], [10], [11]
D0075		Amphotericin B	C47H73NO17	5280965	Moderate		Inter Info	[94], [95], [1]
D0076		Amphotericin B (cholesteryl sulfate)	C47H73NO17	5280965	Moderate		Inter Info	[94], [95], [1]
D0077		Amphotericin B (lipid complex)	C47H73NO17	5280965	Moderate		Inter Info	[94], [95], [1]
D0078		Amphotericin B (liposomal)	C47H73NO17	5280965	Moderate		Inter Info	[94], [95], [1]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[96]
D0273		Cefalotin	C16H16N2O6S2	6024	Moderate		Inter Info	[97], [98], [99]
D0281		Cefixime	C16H15N5O7S2	5362065	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0282		Cefmetazole	C15H17N7O5S3	42008	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0285		Cefotaxime	C16H17N5O7S2	5742673	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[134]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[135], [136], [1], [137], [138], [139]
D0570		Enflurane	C3H2ClF5O	3226	Moderate		Inter Info	[140]
D0718		Gentamicin	C21H43N5O7	3467	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D0719		Gentamicin (topical)	C21H43N5O7	3467	Moderate		Inter Info	[55]
D1009		Mesalazine	C7H7NO3	4075	Moderate		Inter Info	[155], [156], [157]
D0145		Balsalazide	C17H15N3O6	54585	Moderate		Inter Info	[163], [155], [156], [157]
D0274		Cefamandole	C18H18N6O5S2	456255	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0275		Cefapirin	C17H17N3O6S2	30699	Moderate		Inter Info	[97], [98], [99]
D0276		Cefazolin	C14H14N8O4S3	33255	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0279		Cefepime	C19H24N6O5S2	5479537	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0283		Cefonicid	C18H18N6O8S3	43594	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0284		Cefoperazone	C25H27N9O8S2	44187	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0286		Cefotetan	C17H17N7O8S4	53025	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0287		Cefoxitin	C16H17N3O7S2	441199	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0289		Cefprozil	C18H19N3O5S	5281006	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0290		Cefradine	C16H19N3O4S	38103	Moderate		Inter Info	[97], [98], [99]
D0291		Ceftaroline fosamil	C22H21N8O8PS4	9852981	Moderate		Inter Info	[97], [98], [99]
D0294		Ceftizoxime	C13H13N5O5S2	6533629	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0295		Ceftolozane	C23H30N12O8S2	53234134	Moderate		Inter Info	[97], [98], [99]
D0296		Ceftriaxone	C18H18N8O7S3	5479530	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0297		Cefuroxime	C16H16N4O8S	5479529	Moderate		Inter Info	[49], [100], [101], [102], [103], [104], [53], [105], [106], [97], [107], [108], [109], [110], [111], [112], [113], [98], [114], [115], [116], [117], [118], [119], [120], [1], [91], [121], [122], [123], [21], [124], [125], [126], [127], [128], [129], [130], [99]
D0724		Givosiran	C78H139N11O30	119058042	Moderate		Inter Info	[53], [55]
D0790		Ifosfamide	C7H15Cl2N2O2P	3690	Moderate		Inter Info	[53], [55]
D0876		Kanamycin	C18H36N4O11	6032	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D1030		Methoxyflurane	C3H4Cl2F2O	4116	Moderate		Inter Info	[55]
D1173		Olsalazine	C14H10N2O6	22419	Moderate		Inter Info	[163], [155], [156], [157]
D1304		Plazomicin	C25H48N6O10	42613186	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D1507		Streptomycin	C21H39N7O12	19649	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D1126		Netilmicin	C21H41N5O7	441306	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D1138		Nimodipine	C21H26N2O7	4497	Moderate		Inter Info	[53], [55]
D1517		Sulfasalazine	C18H14N4O5S	5339	Moderate		Inter Info	[163], [155], [156], [157]
D1597		Tobramycin	C18H37N5O9	36294	Moderate		Inter Info	[53], [55], [28], [89], [90], [10], [11], [14], [1], [2], [91], [92], [93]
D1672		Valaciclovir	C13H20N6O4	135398742	Moderate		Inter Info	[55], [178]
D1680		Vancomycin	C66H75Cl2N9O24	14969	Moderate		Inter Info	[179], [180], [181], [182], [183], [184]
Pharmacodynamic antagonistic effects
	Antagonize the effect of vaccine/toxoid					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[55], [83], [84]
D1693		Vibrio cholerae CVD 103-HgR strain live antigen (live)	NA	NA	Major		Inter Info	[85]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0606		Estradiol	C18H24O2	5757	Moderate		Inter Info	[143], [144], [145]
D0619		Ethinylestradiol	C20H24O2	5991	Moderate		Inter Info	[143], [144], [145]
D1011		Mestranol	C21H26O2	6291	Moderate		Inter Info	[143], [144], [145]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[166], [167], [168]

References
1	Product Information. Arikayce (amikacin liposome). Insmed Incorporated, Bridgewater, NJ.
2	Product Information. Garamycin (gentamicin). Schering-Plough Corporation, Kenilworth, NJ.
3	Lindesmith LA, Baines RD Jr, Bigelow DB, Petty TL "Reversible respiratory paralysis associated with polymyxin therapy." Ann Intern Med 68 (1968): 318-27.[PMID: 4306125]
4	Product Information. Myobloc (botulinum toxin type B) Elan Pharmaceuticals, S. San Francisco, CA.
5	Product Information. Dysport (abobotulinumtoxinA). Tercica Inc, Brisbane, CA.
6	Product Information. Jeuveau (prabotulinumtoxinA). Evolus, Inc., Santa Barbara, CA.
7	Athlin L, Domellof L, Holm S "Gentamicin treatment in severe surgical infections: serum levels, interactions, toxicity and efficacy." Acta Chir Scand 147 (1981): 225-30. [PMID: 7034430]
8	Bates DE, Beaumont SJ, Baylis BW "Ototoxicity induced by gentamicin and furosemide." Ann Pharmacother 36 (2002): 446-51. [PMID: 11895059]
9	Bruun JN, Eng J, Arnesen AR "Tobramycin therapy of serious infections." Scand J Infect Dis 13 (1981): 59-64. [PMID: 7244560]
10	Kaka JS, Lyman C, Kilarski DJ "Tobramycin-furosemide interaction." Drug Intell Clin Pharm 18 (1984): 235-8. [PMID: 6697885]
11	Lawson DH, Tilstone WJ, Gray JM, Srivastava PK "Effect of furosemide on the pharmacokinetics of gentamicin in patients." J Clin Pharmacol 22 (1982): 254-8. [PMID: 7107971]
12	Leary WP, Reyes AJ "Drug interactions with diuretics." S Afr Med J 65 (1984): 455-61. [PMID: 6701709]
13	Lynn AM, Redding GJ, Morray JP, Tyler DC "Isolated deafness following recovery from neurologic injury and adult respiratory distress syndrome. A sequela of intercurrent aminoglycoside and diuretic use." Am J Dis Child 139 (1985): 464-6. [PMID: 3984969]
14	Mathog RH, Klein WJ "Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia." N Engl J Med 280 (1969): 1223-4. [PMID: 5767464]
15	Meriwether WD, Mangi RJ, Serpick AA "Deafness following standard intravenous dose of ethacrynic acid." JAMA 216 (1971): 795-8. [PMID: 5108285]
16	Moore RD, Smith CR, Lipsky JJ "Risk factors for nephrotoxicity in patients treated with aminoglycosides." Ann Intern Med 100 (1984): 352-7. [PMID: 6364908]
17	Product Information. Lasix (furosemide). sanofi-aventis , Bridgewater, NJ.
18	Product Information. Tobi tobramycin solution for inhalation (tobramycin) PathoGenesis, Skokie, IL.
19	Quick CA, Hoppe W "Permanent deafness associated with furosemide administration." Ann Otol Rhinol Laryngol 84 (1975): 94-101. [PMID: 1089388]
20	Salamy A, Eldredge L, Tooley WH "Neonatal status and hearing loss in high-risk infants." J Pediatr 114 (1989): 847-52. [PMID: 2715898]
21	Schentag JJ, Cerra FB, Plaut ME "Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients." Antimicrob Agents Chemother 21 (1982): 721-6. [PMID: 7103453]
22	Smith CR, Lietman PS "Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans." Antimicrob Agents Chemother 23 (1983): 133-7. [PMID: 6830203]
23	Tilstone WJ, Semple PF, Lawson DH, Boyle JA "Effects of furosemide on glomerular filtration rate and clearance of practolol, digoxin, cephaloridine, and gentamicin." Clin Pharmacol Ther 22 (1977): 389-94. [PMID: 902451]
24	Whiting PH, Barber HE, Petersen J "The effect of frusemide and piretanide on the renal clearance of gentamicin in man." Br J Clin Pharmacol 12 (1981): 795-9. [PMID: 7340881]
25	Product Information. Vistide (cidofovir). Gilead Sciences, Foster City, CA.
26	Burkett L, Bikhazi GB, Thomas KC Jr, Rosenthal DA, Wirta MG, Foldes FF "Mutual potentiation of the neuromuscular effects of antibiotics and relaxants." Anesth Analg 58 (1979): 107-15. [PMID: 571233]
27	Chapple DJ, Clark JL, Hughes R "Interaction between atracurium and drugs used in anaesthesia." Br J Anaesth 55 Suppl (1983): s17-22. [PMID: 6688011]
28	Dupuis JY, Martin R, Tetrault JP "Atracurium and vecuronium interaction with gentamicin and tobramycin." Can J Anaesth 36 (1989): 407-11. [PMID: 2569365]
29	Geha DG, Blitt CD, Moon BJ "Prolonged neuromuscular blockade with pancuronium in the presence of acute renal failure: a case report." Anesth Analg 55 (1976): 343-5. [PMID: 945014]
30	Giala M, Sareyiannis C, Cortsaris N, Paradelis A, Lappas DG "Possible interaction of pancuronium and tubocurarine with oral neomycin." Anaesthesia 37 (1982): 776. [PMID: 7103026]
31	Giala MM, Paradelis AG "Two cases of prolonged respiratory depression due to interaction of pancuronium with colistin and streptomycin." J Antimicrob Chemother 5 (1979): 234-5. [PMID: 429254]
32	Hasfurther DL, Bailey PL "Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin." Can J Anaesth 43 (1996): 617-20. [PMID: 8773869]
33	Jedeikin R, Dolgunski E, Kaplan R, Hoffman S "Prolongation of neuromuscular blocking effect of vecuronium by antibiotics." Anaesthesia 42 (1987): 858-60. [PMID: 2889390]
34	Kronenfeld MA, Thomas SJ, Turndorf H "Recurrence of neuromuscular blockade after reversal of vecuronium in a patient receiving polymyxin/amikacin sternal irrigation." Anesthesiology 65 (1986): 93-4. [PMID: 2873764]
35	Levanen J, Nordman R "Complete respiratory paralysis caused by a large dose of streptomycin and its treatment with calcium chloride." Ann Clin Res 7 (1975): 47-9. [PMID: 1155911]
36	Lippmann M, Yang E, Au E, Lee C "Neuromuscular blocking effects of tobramycin, gentamicin, and cefazolin." Anesth Analg 61 (1982): 767-70. [PMID: 7201757]
37	Pittinger CB, Eryasa Y, Adamson R "Antibiotic-induced paralysis." Anesth Analg 49 (1970): 487-501. [PMID: 4102601]
38	Product Information. Humatin (paromomycin). Parke-Davis, Morris Plains, NJ.
39	Regan AG, Perumbetti PP "Pancuronium and gentamicin interaction in patients with renal failure." Anesth Analg 59 (1980): 393. [PMID: 6989291]
40	Vanacker BF, Van de Walle J "The neuromuscular blocking action of vecuronium in normal patients and in patients with no renal function and interaction vecuronium- tobramycin in renal transplant patients." Acta Anaesthesiol Belg 37 (1986): 95-9. [PMID: 2875595]
41	Warner WA, Sanders E "Neuromuscular blockade associated with gentamicin therapy." JAMA 215 (1971): 1153-4. [PMID: 4250687]
42	Wong GT, Lee EY, Irwin MG. Contrast induced nephropathy in vascular surgery.?Br J Anaesth. 2016;117 Suppl 2:ii63-ii73. [PMID: 27566809]
43	Bennett WM, Porter GA "Nephrotoxicity of common drugs used by urologists." Urol Clin North Am 17 (1990): 145-56. [PMID: 2407013]
44	Bentley ML, Corwin HL, Dasta J "Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies." Crit Care Med 38(6 Suppl) (2010): S169-74. [PMID: 20502171]
45	Dubrovskaya Y, Prasad N, Lee Y, Esaian D, Figueroa DA, Tam VH "Risk factors for nephrotoxicity onset associated with polymyxin B therapy." J Antimicrob Chemother 70 (2015): 1903-7. [PMID: 25652747]
46	Kellum JA, Leblanc M, Venkataraman R "Acute renal failure." BMJ Clin Evid 9 (2008): 2001. [PMID: 19445797]
47	Marcos LA, Camins BC, Ritchie DJ, Casabar E, Warren DK "Acute renal insufficiency during telavancin therapy in clinical practice." J Antimicrob Chemother 67 (2012): 723-6. [PMID: 22174040]
48	van den Berk G, Tonino S, de Fijter C, Smit W, Schultz MJ "Bench-to-bedside review: Preventative measures for contrast-induced nephropathy in critically ill patients." Crit Care 9 (2005): 361-70. [PMID: 16137385]
49	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
50	Blanshard C "Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet." J Acquir Immune Defic Syndr 5 (1992): s25-8. [PMID: 1318364]
51	Cacoub P, Deray G, Baumelou A, et al "Acute renal failure induced by foscarnet: 4 cases." Clin Nephrol 29 (1988): 315-8. [PMID: 2840226]
52	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
53	Cerner Multum, Inc. "Australian Product Information.".
54	Cerner Multum, Inc. "Canadian Product Information.".
55	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
56	Cotte L, Langlois M, Trepo C "Herpes simplex virus infection during foscarnet therapy." J Infect Dis 166 (1992): 447-8. [PMID: 1321865]
57	Deray G, Katlama C, Dohin E "Prevention of foscarnet nephrotoxicity." Ann Intern Med 113 (1990): 332. [PMID: 2165372]
58	Deray G, Le Hoang P, Soubrie C, et al "Foscarnet-induced acute renal failure and effectiveness of haemodialysis." Lancet 2 (1987): 216. [PMID: 2885666]
59	Deray G, Martinez F, Katlama C, et al "Foscarnet nephrotoxicity: mechanism, incidence and prevention." Am J Nephrol 9 (1989): 316-21. [PMID: 2554731]
60	Farese RV Jr, Schambelan M, Hollander H, et al "Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis." Ann Intern Med 112 (1990): 955-6. [PMID: 2160217]
61	Jacobson MA "Review of the toxicities of foscarnet." J Acquir Immune Defic Syndr 5 (1992): s11-7. [PMID: 1534839]
62	Palestine AG, Polis MA, De Smet MD, et al "A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS." Ann Intern Med 115 (1991): 665-73. [PMID: 1656826]
63	Product Information. Amikin (amikacin). Bristol-Myers Squibb, Princeton, NJ.
64	Product Information. Foscavir (foscarnet). Astra USA, Westborough, MA.
65	Product Information. Gentamicin Sulfate, Injectable (gentamicin). Fresenius Kabi USA, LLC, Lake Zurich, IL.
66	Ringden O, Lonnqvist B, Paulin T, et al "Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients." J Antimicrob Chemother 17 (1986): 373-87. [PMID: 3009383]
67	SOCA Reseach Group, et al "Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis." N Engl J Med 326 (1992): 213-20. [PMID: 1345799]
68	Willocks L, Brettle R "Foscarnet and pancytopenia." J Antimicrob Chemother 29 (1992): 232. [PMID: 1387130]
69	Guo X, Nzerue C "How to prevent, recognize, and treat drug-induced nephrotoxicity.".
70	Centers for Disease Control and Prevention (CDC). Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.?MMWR Morb Mortal Wkly Rep. 1999;48(24):518-521. [PMID: 10401909]
71	Product Information. BabyBIG (botulism immune globulin). FFF Enterprises, Temecula, CA.
72	Piper BJ, Alinea AA, Wroblewski JR, et al. A Quantitative and Narrative Evaluation of Goodman and Gilman's Pharmacological Basis of Therapeutics. Pharmacy (Basel). 2019;8(1):1. Published 2019 Dec 20. [PMID: 31861770]
73	Canadian Pharmacists Association.
74	L'Hommedieu CS, Nicholas D, Armes DA, et al "Potentiation of magnesium sulfate-induced neuromuscular weakness by gentamicin, tobramycin, and amikacin." J Pediatr 102 (1983): 629-31. [PMID: 6834204]
75	Watson A, Coffey L, Keogh B, McCann SR "Severe hypomagnesaemia and hypocalcaemia following gentamicin therapy." Isr J Med Sci 76 (1983): 381-3. [PMID: 6662662]
76	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
77	Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M "Fanconi Syndrome Due to Deferasirox." Am J Kidney Dis (2009):. [PMID: 19493602]
78	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
79	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
80	Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM "Acute renal, failure associated with the use of ibuprofen in two liver transplant recipients on FK506." Transplantation 57 (1994): 1132-3. [PMID: 7513099]
81	Product Information. Ganite (gallium nitrate). Fujisawa, Deerfield, IL.
82	Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
83	UK government "Typhoid.".
84	American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association (1994).
85	Product Information. Vaxchora (cholera vaccine, live). PaxVax, Miami, FL.
86	Chang JT, Green L, Beitz J "Renal failure with the use of zoledronic acid." N Engl J Med 349 (2003): 1676-9 discussion 1676-9. [PMID: 14573746]
87	Kanis JA, Preston CJ, Yates AJ, Percival RC, Mundy KI, Russell RG "Effects of intravenous diphosphonates on renal function." Lancet 1 (1983): 1328. [PMID: 6134112]
88	Product Information. Zometa (zoledronic acid). Novartis Pharmaceuticals, East Hanover, NJ.
89	Halstenson CE, Hirata CA, Heim-Duthoy KL, Abraham PA, Matzke GR "Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease." Antimicrob Agents Chemother 34 (1990): 128-33. [PMID: 2327747]
90	Johnson AH, Hamilton CH "Kanamycin ototoxicity: possible potentiation by other drugs." South Med J 63 (1970): 511-3. [PMID: 5446818]
91	Product Information. Mycifradin (neomycin). Emerson Laboratories, Texarkana, TX.
92	Product Information. Nebcin (tobramycin). Lilly, Eli and Company, Indianapolis, IN.
93	Weibert R, Keane W, Shapiro F "Carbenicillin inactivation of aminoglycosides in patients with severe renal failure." Trans Am Soc Artif Intern Organs 22 (1976): 439-43. [PMID: 951863]
94	Churchill DN, Seely J "Nephrotoxicity associated with combined gentamicin - amphotericin B therapy." Nephron 19 (1977): 176-81. [PMID: 268496]
95	Product Information. Abelcet (amphotericin B). Liposome Company Inc, The, Princeton, NJ.
96	Product Information. Paraplatin (carboplatin). Bristol-Myers Squibb, Princeton, NJ.
97	Engle JE, Drago J, Carlin B, Schoolwerth AC "Letter: Reversible acute renal failure after cephalothin." Ann Intern Med 83 (1975): 232-3. [PMID: 1147461]
98	Kabins SA, Cohen S "Cephalothin serum levels in the azotemic patient." Antimicrob Agents Chemother 10 (1964): 207-14. [PMID: 14287932]
99	Yasuhara H, Kobayashi S, Sakamoto K, Kamijo K "Pharmacokinetics of amikacin and cephalothin in bedridden elderly patients." J Clin Pharmacol 22 (1982): 403-9. [PMID: 7130429]
100	Aronoff GR, Brier RA, Sloan RS, Brier ME "Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function." Antimicrob Agents Chemother 34 (1990): 1139-42. [PMID: 2203304]
101	Barbhaiya RH, Knupp CA, Pfeffer M, Pittman KA "Lack of pharmacokinetic interaction between cefepime and amikacin in humans." Antimicrob Agents Chemother 36 (1992): 1382-6. [PMID: 1510431]
102	Bobrow SN, Jaffe E, Young RC "Anuria and acute tubular necrosis associated with gentamicin and cephalothin." JAMA 222 (1972): 1546-7. [PMID: 4678426]
103	Cabanillas F, Burgos RC, Rodriguez C, Baldizon C "Nephrotoxicity of combined cephalothin-gentamicin regimen." Arch Intern Med 135 (1975): 850-2. [PMID: 1130930]
104	Carling PC, Idelson BA, Casano AA, Alexander EA, McCabe WR "Nephrotoxicity associated with cephalothin administration." Arch Intern Med 135 (1975): 797-801. [PMID: 1130924]
105	Cockram CS, Richards P, Bax RP "The safety of cefuroxime and gentamicin in patients with reduced renal function." Curr Med Res Opin 6 (1980): 398-403. [PMID: 7363640]
106	Dellinger P, Murphy T, Barza M, et al "Effect of cephalothin on renal cortical concentrations of gentamicin in rats." Antimicrob Agents Chemother 9 (1976): 587-8. [PMID: 1267436]
107	Fanning WL, Gump D, Jick H "Gentamicin and cephalothin-associated rises in blood urea nitrogen." Antimicrob Agents Chemother 10 (1976): 80-2. [PMID: 984759]
108	Fanning WL, Gump D, Jick H "Gentamicin- and cephalothin-associated rises in blood urea nitrogen." Antimicrob Agents Chemother 10 (1976): 80-2. [PMID: 984759]
109	Fillastre JP, Laumonier R, Humbert G, et al "Acute renal failure associated with combined gentamicin and cephalothin therapy." Br Med J 2 (1973): 396-7. [PMID: 4703097]
110	Foord RD "Cephaloridine, cephalothin and the kidney." J Antimicrob Chemother 1 (1975): 119-33. [PMID: 1201976]
111	Gonzalez-Vitale JC, hayes DM, Cvitkovic E, Sternberg SS "Acute renal failure after cis-Dichlorodiammineplatinum (II) and gentamicin-cephalothin therapies." Cancer Treat Rep 62 (1978): 693-8. [PMID: 657154]
112	Gurwich EL, Sula J, Hoy RH "Gentamicin-cephalothin drug reaction." Am J Hosp Pharm 35 (1978): 1402-3. [PMID: 707512]
113	Hansen MM, Kaaber K "Nephrotoxicity in combined cephalothin and gentamicin therapy." Acta Med Scand 201 (1977): 463-7. [PMID: 899868]
114	Klastersky J, Hensgens C, Debusscher L "Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin." Antimicrob Agents Chemother 7 (1975): 640-5. [PMID: 1096809]
115	Kleinknecht D, Ganeval D, Droz D "Acute renal failure after high doses of gentamicin and cephalothin." Lancet 05/19/73 (1973): 1129. [PMID: 4122055]
116	Kleinknecht D, Ganeval D, Droz D "Acute renal failure after high doses of gentamicin and cephalothin." Lancet 1 (1973): 1129. [PMID: 4122055]
117	Krcmery V, Fuchsberger P, Gocar M, et al "Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients." Chemotherapy 37 (1991): 287-91. [PMID: 1790727]
118	Pasternak DP, Stephens BG "Reversible nephrotoxicity associated with cephalothin therapy." Arch Intern Med 135 (1975): 599-602. [PMID: 1138675]
119	Pickering MJ, Spooner GR, Quesada A, de Cade JR "Declining renal function associated with administration of cephalothin." South Med J 63 (1970): 426-8. [PMID: 5437593]
120	Plager JE "Association of renal injury with combined cephalothin-gentamicin therapy among patients severely ill with malignant disease." Cancer 37 (1976): 1937-43. [PMID: 1260696]
121	Renal failure in combined gentamicin and cephalothin therapy. Br Med J 2 (1973): 776-7. [PMID: 4718331]
122	Rodjer S, Alestig K, Bergmark J, et al "Treatment of septicaemia in immunocompromised patients with ceftazidime, or with tobramycin and cefuroxime, with special reference to renal effects." J Antimicrob Chemother 20 (1987): 109-16. [PMID: 3305460]
123	Sanders WE, Jr Johnson JE, 3d Taggart JG "Adverse reactions to cephalothin and cephapirin. Uniform occurrence on prolonged intravenous administration of high doses." N Engl J Med 290 (1974): 424-9. [PMID: 4811017]
124	Schultze RG, Winters RE, Kauffman H "Possible nephrotoxicity of gentamicin." J Infect Dis 124 (1971): s145-7. [PMID: 5126240]
125	Schwartz JH, Schein P "Fanconi syndrome associated with cephalothin and gentamicin therapy." Cancer 41 (1978): 769-72. [PMID: 343914]
126	Tobias JS, Whitehouse JM, Wrigley PF "Letter: Severe renal dysfunction after tobramycin/cephalothin therapy." Lancet 1 (1976): 425. [PMID: 55686]
127	Trollfors B, Alestig K, Rodjer S, Sandberg T, Westin J "Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G." J Antimicrob Chemother 12 (1983): 641-5. [PMID: 6363382]
128	Tvedegaard E "Letter: Interaction between gentamicin and cephalothin as cause of acute renal failure." Lancet 2 (1976): 581. [PMID: 60663]
129	Wade J, Smith C, Petty B, et al "Nephrotoxicity of gentamicin or tobramycin with methicillin or cephalothin." Curr Chem 2 (1978): 971-2.
130	Wade JC, Smith CR, Petty BG, et al "Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside." Lancet 2 (1978): 604-6. [PMID: 80528]
131	Hass A, Anderson L, Lad T "The influence of aminoglycosides on the nephrotoxicity of cis-diamminedichlorophatinum in cancer patients." J Infect Dis 147 (1983): 363
132	Dentino M, Luft FC, Yum MN, et al "Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man." Cancer 41 (1978): 1274-81
133	Blachley JD, Hill JB "Renal and electrolyte disturbances associated with cisplatin." Ann Intern Med 95 (1981): 628-32
134	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
135	Chandrasekar PH, Cronin SM "Nephrotoxicity in bone marrow transplant recipients receiving aminoglycoside plus cyclosporine or aminoglycoside alone." J Antimicrob Chemother 27 (1991): 845-9. [PMID: 1938691]
136	Cockburn IT, Krupp P "An appraisal of drug interactions with sandimmun." Transplant Proc 21 (1989): 3845-50. [PMID: 2683269]
137	Product Information. Sandimmune (cyclosporine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
138	Termeer A, Hoitsma AJ, Koene RA "Severe nephrotoxicity caused by the combined use of gentamicin and cyclosporine in renal allograft recipients." Transplantation 42 (1986): 220-1. [PMID: 3526659]
139	Whiting PH, Simpson JG "The enhancement of cyclosporin A-induced nephrotoxicity by gentamicin." Biochem Pharmacol 32 (1983): 2025-8. [PMID: 6870931]
140	Motuz DJ, Watson WA, Barlow JC, et al "The increase in urinary alanine aminopeptidase excretion associated with enflurane anesthesia is increased further by aminoglycosides." Anesth Analg 67 (1988): 770-4. [PMID: 2899408]
141	Product Information. Baraclude (entecavir). Bristol-Myers Squibb, Princeton, NJ.
142	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs).".
143	Back DJ, Breckenridge AM, Crawford FE, MacIver M, Orne ML, Rowe PH "Interindividual variation and drug interactions with hormonal steroid contraceptives." Drugs 21 (1981): 46-61. [PMID: 7009137]
144	Barnett ML "Inhibition of oral contraceptive effectiveness by concurrent antibiotic administration." J Periodontol 56 (1985): 18-20. [PMID: 3882930]
145	King VJ "OC failure rates and oral antibiotics." J Fam Pract 45 (1997): 104-5. [PMID: 9267366]
146	Banerjee D, Asif A, Striker L, Preston RA, Bourgoignie JJ, Roth D "Short-term, high-dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity." Am J Kidney Dis 41 (2003): E18. [PMID: 12778436]
147	Chang JT, Green L, Beitz J "Renal failure with the use of zoledronic acid." N Engl J Med 349 (2003): 1676-9 discussion 1676-9. [PMID: 14573746]
148	Janssen Van Doorn K, Neyns B, Van Der Niepen P, Verbeelen D "Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases." Nephron 89 (2001): 467-8. [PMID: 11721169]
149	Lockridge L, Papac RJ, Perazella MA "Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis." Am J Kidney Dis 40 (2002): E2. [PMID: 12087588]
150	Markowitz GS, Fine PL, Stack JI, et al. "Toxic acute tubular necrosis following treatment with zoledronate (Zometa)." Kidney Int 64 (2003): 281-289. [PMID: 12787420]
151	Osullivan TL, Akbari A, Cadnapaphornchai P "Acute renal failure associated with the administration of parenteral etidronate." Ren Fail 16 (1994): 767-73. [PMID: 7899588]
152	Pedersen-Bjergaard U, Myhre J "Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside." Br Med J 302 (1991): 295. [PMID: 1825614]
153	Product Information. Ostac (clodronate). Hoffmann-La Roche Limited, Mississauga, IA.
154	Zazgornik J, Grafinger P, Biesenbach G, Hubmann R, Fridrik M "Acute renal failure and alendronate." Nephrol Dial Transplant 12 (1997): 2797-8. [PMID: 9430905]
155	Product Information. Canasa (mesalamine (5-aminosalicylic acid)). Axcan Scandipharm Inc, Birmingham, AL.
156	Product Information. Lialda (mesalamine (5-aminosalicylic acid)). Shire US Inc, Florence, KY.
157	Schreiber S. Hamling J, Zehnter E, et al "Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate." Gut 40 (1997): 761-6. [PMID: 9245930]
158	Keusch GT, Troncale FJ, Buchanan RD "Malabsorption due to paromomycin." Arch Intern Med 125 (1970): 273-6. [PMID: 5412015]
159	Shen DD, Azarnoff DL "Clinical pharmacokinetics of methotrexate." Clin Pharmacokinet 3 (1978): 1-13. [PMID: 346283]
160	Cohen MH, Creaven PJ, Fossieck BE, Johnston AV, Williams CL "Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients." Cancer 38 (1976): 1556-9. [PMID: 186170]
161	Product Information. CellCept (mycophenolate mofetil). Roche Laboratories, Nutley, NJ.
162	Product Information. Myfortic (mycophenolic acid). Novartis Pharmaceuticals, East Hanover, NJ.
163	Novis BH, Korzets Z, Chen P, Bernheim J "Nephrotic syndrome after treatment with 5-aminosalicylic acid." Br Med J (Clin Res Ed) 296 (1988): 1442. [PMID: 3132281]
164	Product Information. Ancobon (flucytosine). Roche Laboratories, Nutley, NJ.
165	Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
166	Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate). Ferring Pharmaceuticals Inc, Tarrytown, NY.
167	MHRA. Medicines and Healthcare Regulatory Agency (general site Reference).
168	Product Information. Clenpiq (citric acid/Mg oxide/Na picosulfate). Ferring Pharmaceuticals Inc, Tarrytown, NY.
169	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
170	Gilead Sciences, Inc "About Remdesivir.".
171	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
172	Product Information. Tyzeka (telbivudine). IDEC Pharmaceuticals Corporation, San Diego, CA.
173	Product Information. Eloxatin (oxaliplatin). Sanofi Winthrop Pharmaceuticals, New York, NY.
174	Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
175	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
176	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
177	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
178	Product Information. Valtrex (valacyclovir). Glaxo Wellcome, Research Triangle Park, NC.
179	Dean RP, Wagner DJ, Tolpin MD "Vancomycin/aminoglycoside nephrotoxicity." J Pediatr 106 (1985): 861-2. [PMID: 3998936]
180	Downs NJ, Neihart RE, Dolezal JM, Hodges GR "Mild nephrotoxicity associated with vancomycin use." Arch Intern Med 149 (1989): 1777-81. [PMID: 2764651]
181	Farber BF, Moellering RC Jr "Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981." Antimicrob Agents Chemother 23 (1983): 138-41. [PMID: 6219616]
182	Odio C, McCracken GH, Nelson JD "Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children." J Pediatr 105 (1984): 491-2. [PMID: 6470874]
183	Pauly DJ, Musa DM, Lestico MR, Lindstrom MJ, Hetsko CM "Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy." Pharmacotherapy 10 (1990): 378-82. [PMID: 2287556]
184	Sorrell TC, Collignon PJ "A prospective study of adverse reactions associated with vancomycin therapy." J Antimicrob Chemother 16 (1985): 235-41. [PMID: 3934126]
185	Lindenbaum J, Maulitz RM, Butler VP "Inhibition of digoxin absorption by neomycin." Gastroenterology 71 (1976): 399-404. [PMID: 950089]
186	Lindenbaum J, Tse-Eng D, Butler VP, Rund DG "Urinary excretion of reduced metabolites of digoxin." Am J Med 71 (1981): 67-74. [PMID: 7246583]
187	Rodin SM, Johnson BF "Pharmacokinetic interactions with digoxin." Clin Pharmacokinet 15 (1988): 227-44. [PMID: 3056649]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence